Literature DB >> 31084472

Influenza and pneumonia vaccination rates in patients hospitalized with acute respiratory failure.

Ipek Candemir1, Sema Turk1, Pinar Ergun1, Dicle Kaymaz1.   

Abstract

Background and method: Despite their proven effect, the rates of vaccinations are low. The aim of this study was to determine the rates and associated factors of influenza and pneumonia vaccinations in patients who were hospitalized because of acute respiratory failure. Patients hospitalized because of acute hypoxemic or hypercapnic respiratory failure were recruited for this retrospective study. A survey was conducted with 97 patients. Primary diagnoses, ages, reasons of hospitalizations, education status, vaccination rates, information resources, and thoughts about vaccinations were recorded.
Results: In total 45 (46%) of the patients were female, and 52 (54%) were male. The mean age was 67 ± 12 years. The primary diagnoses were lung disorders (n = 77, 79%), cardiac disorders (n = 16, 17%), and neuromuscular disorders (n = 5, 4%). In total 72 (74%) patients had chronic obstructive pulmonary disease (COPD) with primary lung disorders. All patients were hospitalized due to acute respiratory failure. The main reason for acute respiratory failure was infection in 40 patients (42%). The overall influenza and pneumococcal vaccination rates were 26% and 15%, respectively; for patients with COPD it was 30% and 17%, respectively. The main providers of information were doctors (42%). Vaccination status was not associated with infections or other reasons of hospitalization, age, sex, educational status, and number of hospital admissions in the previous year. A total of 51 patients (52%) had no belief in the benefits of vaccinations.
Conclusion: Vaccination rates were found to be low in patients who were frequently hospitalized. Vaccination status was not related with hospitalization due to infections and history of hospitalization; awareness of vaccinations should be improved both in doctors and patients.

Entities:  

Keywords:  Vaccination; affecting factors; chronic disease; hospitalization

Mesh:

Substances:

Year:  2019        PMID: 31084472      PMCID: PMC6930043          DOI: 10.1080/21645515.2019.1613128

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  35 in total

1.  The impact of socioeconomic level on influenza vaccination among Italian adults and elderly: a cross-sectional study.

Authors:  G Damiani; B Federico; M Visca; F Agostini; W Ricciardi
Journal:  Prev Med       Date:  2007-07-17       Impact factor: 4.018

2.  Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-10-12       Impact factor: 17.586

3.  Determinants of pneumococcal vaccination among patients with chronic obstructive pulmonary disease in Spain.

Authors:  Maria C Ariñez-Fernandez; Pilar Carrasco-Garrido; Marta Garcia-Carballo; Valentín Hernández-Barrera; Angel Gil de Miguel; Rodrigo Jiménez-García
Journal:  Hum Vaccin       Date:  2006-05-25

4.  Pneumococcal Vaccine Coverage in Adults Aged 19-64 Years, Newly Diagnosed With Chronic Conditions in the U.S.

Authors:  Tanaz Petigara; Dongmu Zhang
Journal:  Am J Prev Med       Date:  2018-03-15       Impact factor: 5.043

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405

Review 6.  Vaccines for preventing pneumococcal infection in adults.

Authors:  S A Moberley; J Holden; D P Tatham; R M Andrews
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

7.  The effect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological Study "diaVAX".

Authors:  Ilhan Satman; Sema Akalin; Bekir Cakir; Serdar Altinel
Journal:  Hum Vaccin Immunother       Date:  2013-07-25       Impact factor: 3.452

8.  Influenza and Pneumonia Vaccination Rates and Factors Affecting Vaccination among Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Ülkü Aka Aktürk; Aslı Görek Dilektaşlı; Aysun Şengül; Banu Musaffa Salepçi; Nuray Oktay; Mustafa Düger; Hale Arık Taşyıkan; Nagihan Durmuş Koçak
Journal:  Balkan Med J       Date:  2017-04-06       Impact factor: 2.021

Review 9.  Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk--A Systematic Review and Meta-Analysis.

Authors:  Julia Schiffner-Rohe; Annika Witt; Jana Hemmerling; Christof von Eiff; Friedrich-Wilhelm Leverkus
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

10.  The impact of virus infections on pneumonia mortality is complex in adults: a prospective multicentre observational study.

Authors:  Naoko Katsurada; Motoi Suzuki; Masahiro Aoshima; Makito Yaegashi; Tomoko Ishifuji; Norichika Asoh; Naohisa Hamashige; Masahiko Abe; Koya Ariyoshi; Konosuke Morimoto
Journal:  BMC Infect Dis       Date:  2017-12-06       Impact factor: 3.090

View more
  3 in total

1.  Outcome predictors of influenza for hospitalization and mortality in children.

Authors:  Yasemin Ozsurekci; Kubra Aykac; Fatma Bal; Cihangul Bayhan; Sevgen T Basaranoglu; Alpaslan Alp; Ali Bulent Cengiz; Ates Kara; Mehmet Ceyhan
Journal:  J Med Virol       Date:  2021-02-09       Impact factor: 20.693

2.  Healthcare personnel's attitude and coverage about tetanus vaccination in Turkey: a multicenter study.

Authors:  Derya Seyman; Ayşegül Seremet Keskin; Emine Küçükateş; Mehmet Reşat Ceylan; Gülnur Kul; Selma Tosun; Ayşe Ferdane Oğuzöncül; Özlem Zanapalıoğlu Gazel; Hanife Uzar; Serhat Uysal; Işıl Deniz Aliravcı; Sibel Yıldız Kaya; Mustafa Uğuz; Müçteba Can; Burcu Çalışkan Demirkıran; Halil Kul; Emine Yeşilyurt Şölen; Hüseyin Can; Mustafa Deniz; Bülent Altuntaş
Journal:  Hum Vaccin Immunother       Date:  2022-02-16       Impact factor: 3.452

3.  Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent.

Authors:  Hector F Africano; Cristian C Serrano-Mayorga; Paula C Ramirez-Valbuena; Ingrid G Bustos; Alirio Bastidas; Hernan A Vargas; Sandra Gómez; Alejandro Rodriguez; Carlos J Orihuela; Luis F Reyes
Journal:  Clin Infect Dis       Date:  2021-06-01       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.